Obesity attenuates gender differences in cardiovascular mortality

Cardiovascular Diabetology

Volumn 13, Issue 1, 2014, Pages

  Song, Xin ^a,b   Tabák, Adam G ^c,d   Zethelius, Björn ^e,f   Yudkin, John S ^c   Söderberg, Stefan ^g,h   Laatikainen, Tiina ^b,i,j   Stehouwer, Coen D A ^k   Dankner, Rachel ^l,m   Jousilahti, Pekka ^b   Onat, Altan ⁿ   Nilsson, Peter M ^o,p   Satman, Ilhan ⁿ   Vaccaro, Olga ^q   Tuomilehto, Jaakko ^b,r,s,t   Qiao, Qing ^a,b,u  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d SEMMELWEIS UNIVERSITY   (Hungary)

^e UPPSALA UNIVERSITY   (Sweden)

^f MEDICAL PRODUCTS AGENCY   (Sweden)

^g UMEÅ UNIVERSITY   (Sweden)

^h BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

ⁱ UNIVERSITY OF EASTERN FINLAND   (Finland)

^j Hospital District of North Karelia   (Finland)

^k MAASTRICHT UNIVERSITY   (Netherlands)

^l GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^m TEL AVIV UNIVERSITY   (Israel)

ⁿ ISTANBUL UNIVERSITY   (Turkey)

^o LUND UNIVERSITY   (Sweden)

^p LUND UNIVERSITY HOSPITAL   (Sweden)

^q UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^r DANUBE UNIVERSITY KREMS   (Austria)

^s KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^t HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

^u ASTRAZENECA R AND D   (Sweden)

more..

Author keywords

Cardiovascular disease mortality; Gender; Obesity

Indexed keywords

ABDOMINAL OBESITY; ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PROSPECTIVE STUDY; SEX DIFFERENCE; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WAIST TO HEIGHT RATIO; WOMEN'S HEALTH; AGED; CARDIOVASCULAR DISEASE; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; SEXUAL DEVELOPMENT;

ADULT; AGED; BODY MASS INDEX; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; RISK FACTORS; SEX CHARACTERISTICS; WAIST CIRCUMFERENCE; WAIST-HIP RATIO;

EID: 84964315277     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/s12933-014-0144-5     Document Type: Article

References (69)

1. World Health Organization: The Top 10 Causes of Death. Updated May 2014; Available at: http://who.int/mediacentre/factsheets/fs310/en/index.html. Accessed May 20, 2014.
2. Ramaekers D, Ector H, Aubert AE, Rubens A, Van de Werf F: Heart rate variability and heart rate in healthy volunteers. Is the female autonomic nervous system cardioprotective? Eur Heart J 1998, 19(9):1334-1341.
3. Dart AM, Du XJ, Kingwell BA: Gender, sex hormones and autonomic nervous control of the cardiovascular system. Cardiovasc Res 2002, 53(3):678-687.
4. Vaccarino V, Badimon L, Corti R, de Wit C, Dorobantu M, Hall A, Koller A, Marzilli M, Pries A, Bugiardini R, Working Group on Coronary Pathophysiology and Microcirculation: Ischaemic heart disease in women: are there sex differences in pathophysiology and risk factors? Position paper from the working group on coronary pathophysiology and microcirculation of the European Society of Cardiology. Cardiovasc Res 2011, 90(1):9-17.
5. Moodithaya S, Avadhany ST: Gender differences in age-related changes in cardiac autonomic nervous function. J Aging Res 2012, 2012:679345.
6. Freedman DS, Jacobsen SJ, Barboriak JJ, Sobocinski KA, Anderson AJ, Kissebah AH, Sasse EA, Gruchow HW: Body fat distribution and male/ female differences in lipids and lipoproteins. Circulation 1990, 81(5):1498-1506.
7. Donahue RP, Prineas RJ, DeCarlo DR, Bean JA, Skyler JS: The female 'insulin advantage' in a biracial cohort: results from the Miami Community Health Study. Int J Obes Relat Metab Disord 1996, 20(1):76-82.
8. Garaulet M, Perex-Llamas F, Fuente T, Zamora S, Tebar FJ: Anthropometric, computed tomography and fat cell data in an obese population: relationship with insulin, leptin, tumor necrosis factor-alpha, sex hormone-binding globulin and sex hormones. Eur J Endocrinol 2000, 143(5):657-666.
9. Magkos F, Wang X, Mittendorfer B: Metabolic actions of insulin in men and women. Nutrition 2010, 26(7-8):686-693.
10. Steinberg HO, Paradisi G, Cronin J, Crowde K, Hempfling A, Hook G, Baron AD: Type II diabetes abrogates sex differences in endothelial function in premenopausal women. Circulation 2000, 101(17):2040-2046.
11. Mayes JS, Watson GH: Direct effects of sex steroid hormones on adipose tissues and obesity. Obes Rev 2004, 5(4):197-216.
12. D'Eon TM, Souza SC, Aronovitz M, Obin MS, Fried SK, Greenberg AS: Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways. J Biol Chem 2005, 280(43):35983-35991.
13. Diabetes Prevention Program Research Group: Relationship of body size and shape to the development of diabetes in the diabetes prevention program. Obesity (Silver Spring) 2006, 14(11):2107-2117.
14. Singh R, Artaza JN, Taylor WE, Braga M, Yuan X, Gonzalez-Cadavid NF, Bhasin S: Testosterone inhibits adipogenic differentiation in 3 T3-L1 cells: nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to downregulate adipogenic transcription factors. Endocrinology 2006, 147(1):141-154.
15. Saad MF, Damani S, Gingerich RL, Riad-Gabriel MG, Khan A, Boyadjian R, Jinagouda SD, el-Tawil K, Rude RK, Kamdar V: Sexual dimorphism in plasma leptin concentration. J Clin Endocrinol Metab 1997, 82(2):579-584.
16. Licinio J, Negrao AB, Mantzoros C, Kaklamani V, Wong ML, Bongiorno PB, Negro PP, Mulla A, Veldhuis JD, Cearnal L, Flier JS, Gold PW: Sex differences in circulating human leptin pulse amplitude: clinical implications. J Clin Endocrinol Metab 1998, 83(11):4140-4147.
17. Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, Retzlaff BM, Knopp RH, Brunzell JD, Kahn SE: Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003, 46(4):459-469.
18. Steffes MW, Gross MD, Schreiner PJ, Yu X, Hilner JE, Gingerich R, Jacobs DR Jr: Serum adiponectin in young adults-interactions with central adiposity, circulating levels of glucose, and insulin resistance: the CARDIA study. Ann Epidemiol 2004, 14(7):492-498.
19. Kershaw EE, Flier JS: Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004, 89(6):2548-2556.
20. Barnett SR, Morin RJ, Kiely DK, Gagnon M, Azhar G, Knight EL, Nelson JC, Lipsitz LA: Effects of age and gender on autonomic control of blood pressure dynamics. Hypertension 1999, 33(5):1195-1200.
21. Tremollieres FA, Pouilles JM, Cauneille C, Ribot C: Coronary heart disease risk factors and menopause: a study in 1684 French women. Atherosclerosis 1999, 142(2):415-423.
22. Peters HW, Westendorp IC, Hak AE, Grobbee DE, Stehouwer CD, Hofman A, Witteman JC: Menopausal status and risk factors for cardiovascular disease. J Intern Med 1999, 246(6):521-528.
23. Couillard C, Bergeron J, Despres JP, Gagnon J, Rankinen T, Leon AS, Rao DC, Skinner JS, Wilmore JH, Bouchard C: Apolipoprotein AI-and AI:AIIcontaining lipoproteins in white men and women of the HERITAGE Family study: Associations with metabolic risk profile variables. Metabolism 2003, 52(12):1530-1536.
24. Jousilahti P, Vartiainen E, Tuomilehto J, Puska P: Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland. Circulation 1999, 99(9):1165-1172.
25. Hu G, DECODE Study Group: Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes. Diabetologia 2003, 46(5):608-617.
26. Roche MM, Wang PP: Sex differences in all-cause and cardiovascular mortality, hospitalization for individuals with and without diabetes, and patients with diabetes diagnosed early and late. Diabetes Care 2013, 36(9):2582-2590.
27. Mascarenhas-Melo F, Marado D, Palavra F, Sereno J, Coelho A, Pinto R, Teixeira-Lemos E, Teixeira F, Reis F: Diabetes abrogates sex differences and aggravates cardiometabolic risk in postmenopausal women. Cardiovasc Diabetol 2013, 12:61-2840-12-61.
28. Kahn HS, Bullard KM, Barker LE, Imperatore G: Differences between adiposity indicators for predicting all-cause mortality in a representative sample of United States non-elderly adults. PLoS One 2012, 7(11):e50428.
29. Del Gobbo LC, Song Y, Poirier P, Dewailly E, Elin RJ, Egeland GM: Low serum magnesium concentrations are associated with a high prevalence of premature ventricular complexes in obese adults with type 2 diabetes. Cardiovasc Diabetol 2012, 11:23-2840-11-23.
30. Rider OJ, Lewandowski A, Nethononda R, Petersen SE, Francis JM, Pitcher A, Holloway CJ, Dass S, Banerjee R, Byrne JP, Leeson P, Neubauer S: Genderspecific differences in left ventricular remodelling in obesity: insights from cardiovascular magnetic resonance imaging. Eur Heart J 2013, 34(4):292-299.
31. Martins RA, Jones JG, Cumming SP, Silva MJ C e, Teixeira AM, Verissimo MT: Glycated hemoglobin and associated risk factors in older adults. Cardiovasc Diabetol 2012, 11:13-2840-11-13.
32. Shelton NJ: Regional risk factors for health inequalities in Scotland and England and the "Scottish effect". Soc Sci Med 2009, 69(5):761-767.
33. Han TS, Sattar N, Williams K, Gonzalez-Villalpando C, Lean ME, Haffner SM: Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care 2002, 25(11):2016-2021.
34. Willett WC, Dietz WH, Colditz GA: Guidelines for healthy weight. N Engl J Med 1999, 341(6):427-434.
35. Kahn SE, Hull RL, Utzschneider KM: Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006, 444(7121):840-846.
36. World Health Organization: Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000, 894(i-xii):1-253.
37. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998, 15(7):539-553.
38. Suliga E: Visceral adipose tissue in children and adolescents: a review. Nutr Res Rev 2009, 22(2):137-147.
39. Wajchenberg BL: Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000, 21(6):697-738.
40. Klein S: The case of visceral fat: argument for the defense. J Clin Invest 2004, 113(11):1530-1532.
41. Carey DG: Abdominal obesity. Curr Opin Lipidol 1998, 9(1):35-40.
42. Ross R, Shaw KD, Rissanen J, Martel Y, de Guise J, Avruch L: Sex differences in lean and adipose tissue distribution by magnetic resonance imaging: anthropometric relationships. Am J Clin Nutr 1994, 59(6):1277-1285.
43. Kuk JL, Lee S, Heymsfield SB, Ross R: Waist circumference and abdominal adipose tissue distribution: influence of age and sex. Am J Clin Nutr 2005, 81(6):1330-1334.
44. Camhi SM, Bray GA, Bouchard C, Greenway FL, Johnson WD, Newton RL, Ravussin E, Ryan DH, Smith SR, Katzmarzyk PT: The relationship of waist circumference and BMI to visceral, subcutaneous, and total body fat: sex and race differences. Obesity (Silver Spring) 2011, 19(2):402-408.
45. Cameron AJ, Magliano DJ, Söderberg S: A systematic review of the impact of including both waist and hip circumference in risk models for cardiovascular diseases, diabetes and mortality. Obes Rev 2013, 14(1):86-94.
46. Louet JF, LeMay C, Mauvais-Jarvis F: Antidiabetic actions of estrogen: insight from human and genetic mouse models. Curr Atheroscler Rep 2004, 6(3):180-185.
47. Ferrara A, Barrett-Connor E, Wingard DL, Edelstein SL: Sex differences in insulin levels in older adults and the effect of body size, estrogen replacement therapy, and glucose tolerance status. The Rancho Bernardo Study, 1984-1987. Diabetes Care 1995, 18(2):220-225.
48. Söderberg S, Stegmayr B, Stenlund H, Sjöström LG, Agren A, Johansson L, Weinehall L, Olsson T: Leptin, but not adiponectin, predicts stroke in males. J Intern Med 2004, 256(2):128-136.
49. Lilja M, Rolandsson O, Norberg M, Söderberg S: The impact of leptin and adiponectin on incident type 2 diabetes is modified by sex and insulin resistance. Metab Syndr Relat Disord 2012, 10(2):143-151.
50. Rabin KR, Kamari Y, Avni I, Grossman E, Sharabi Y: Adiponectin: linking the metabolic syndrome to its cardiovascular consequences. Expert Rev Cardiovasc Ther 2005, 3(3):465-471.
51. Oh DK, Ciaraldi T, Henry RR: Adiponectin in health and disease. Diabetes Obes Metab 2007, 9(3):282-289.
52. Arone LJ, Mackintosh R, Rosenbaum M, Leibel RL, Hirsch J: Autonomic nervous system activity in weight gain and weight loss. Am J Physiol 1995, 269(1 Pt 2):R222-R225.
53. Karason K, Molgaard H, Wikstrand J, Sjostrom L: Heart rate variability in obesity and the effect of weight loss. Am J Cardiol 1999, 83(8):1242-1247.
54. Flier JS: Obesity wars: molecular progress confronts an expanding epidemic. Cell 2004, 116(2):337-350.
55. Onat A, Can G: Enhanced proinflammatory state and autoimmune activation: a breakthrough to understanding chronic diseases. Curr Pharm Des 2014, 20(4):575-584.
56. Despres JP, Moorjani S, Lupien PJ, Tremblay A, Nadeau A, Bouchard C: Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis 1990, 10(4):497-511.
57. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C, National Heart, Lung, and Blood Institute, American Heart Association: Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol 2004, 24(2):e13-e18.
58. Tchernof A, Poehlman ET, Despres JP: Body fat distribution, the menopause transition, and hormone replacement therapy. Diabetes Metab 2000, 26(1):12-20.
59. Stanworth RD, Jones TH: Testosterone in obesity, metabolic syndrome and type 2 diabetes. Front Horm Res 2009, 37:74-90.
60. Jones TH: Testosterone deficiency: a risk factor for cardiovascular disease? Trends Endocrinol Metab 2010, 8(21(8)):496-503.
61. Bulow B, Hagmar L, Eskilsson J, Erfurth EM: Hypopituitary females have a high incidence of cardiovascular morbidity and an increased prevalence of cardiovascular risk factors. J Clin Endocrinol Metab 2000, 85(2):574-584.
62. Havel PJ: Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism. Diabetes 2004, 53(Suppl 1):S143-S151.
63. Montague CT, Prins JB, Sanders L, Digby JE, O'Rahilly S: Depot-and sexspecific differences in human leptin mRNA expression: implications for the control of regional fat distribution. Diabetes 1997, 46(3):342-347.
64. Westerbacka J, Cornér A, Tiikkainen M, Tamminen M, Vehkavaara S, Häkkinen AM, Fredriksson J, Yki-Järvinen H: Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk. Diabetologia 2004, 47(8):1360-1369.
65. Stramba-Badiale M, Fox KM, Priori SG, Collins P, Daly C, Graham I, Jonsson B, Schenck-Gustafsson K, Tendera M: Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology. Eur Heart J 2006, 27(8):994-1005.
66. Carpenter KM, Hasin DS, Allison DB, Faith MS: Relationships between obesity and DSM-IV major depressive disorder, suicide ideation, and suicide attempts: results from a general population study. Am J Public Health 2000, 90(2):251-257.
67. Expert WHO: Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004, 363(9403):157-163.
68. Kotani K, Tokunaga K, Fujioka S, Kobatake T, Keno Y, Yoshida S, Shimomura I, Tarui S, Matsuzawa Y: Sexual dimorphism of age-related changes in whole-body fat distribution in the obese. Int J Obes Relat Metab Disord 1994, 18(4):207-202.
69. Sites CK, Brochu M, Tchernof A, Poehlman ET: Relationship between hormone replacement therapy use with body fat distribution and insulin sensitivity in obese postmenopausal women. Metabolism 2001, 50(7):835-840.